Stock Market Reviews

FTRE (Fortrea Holdings Inc.) News

Get the latest news, insights, and market updates on FTRE (Fortrea Holdings Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 3 Inflated Stocks with Open Questions
  Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
  Dec 29, 2025 - $FTRE
• 3 Stocks Under $50 Walking a Fine Line
  The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
  Dec 25, 2025 - $FTRE
• Why Fortrea (FTRE) Stock Is Up Today
  Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 8% in the afternoon session after an analyst at Mizuho raised the firm's price target on the stock while maintaining a Neutral rating.
  Dec 19, 2025 - $FTRE
• Fortrea (FTRE): Reassessing Valuation After a Sharp 3-Month Share Price Rebound
  Fortrea Holdings (FTRE) has quietly shifted gears, with the share price jumping about 65% over the past month and roughly 64% in the past 3 months, reversing earlier weakness. See our latest analysis for Fortrea Holdings. That surge sits against a tougher backdrop, with the year to date share price return still negative and the 1 year total shareholder return down double digits. This suggests sentiment has quickly shifted toward a recovery story. If Fortrea’s sharp rebound has you thinking...
  Dec 19, 2025 - $FTRE
• Why Fortrea (FTRE) Stock Is Trading Up Today
  Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 5.7% in the morning session after an analyst at Mizuho raised the company's price target. Analyst Ann Hynes reaffirmed a neutral stance on Fortrea Holdings but increased the price target to $13.00 from a previous $11.00.
  Dec 18, 2025 - $FTRE
• Why Fortrea (FTRE) Stock Is Up Today
  Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 6.2% in the afternoon session after Citigroup upgraded the stock's rating to Buy from Neutral and significantly raised its price target. The analyst firm increased its price target by 75%, from $12.00 to $21.00. This positive shift reflected the firm's renewed confidence in Fortrea Holdings' market performance and future prospects, according to the analyst report.
  Dec 11, 2025 - $FTRE
• Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
  DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on December 10, 2025, to two newly hired employees. The award consisted of 245,000 RSUs that vest in three equal annual installments starting December 10, 2026, subject to the employee’s continuous employment through the applicable vesting date. The RSUs are subject to the te
  Dec 10, 2025 - $FTRE
• SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
  PRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), today announced a strategic collaboration agreement between the two companies. This partnership aims to streamline development, accelerate timelines and bring advanced therapies to patients faster. This collaboration represents a forward-looking model for how CDMOs
  Dec 4, 2025 - $FTRE
• Fortrea (FTRE) Valuation Check After Investigation into Alleged Overstated Revenue, Cost Savings, and 2025 EBITDA Targets
  Fortrea Holdings (FTRE) is back in the spotlight after a shareholder rights firm launched an investigation into whether management overstated revenue, cost savings, and 2025 EBITDA goals, raising fresh questions about its post spin off story. See our latest analysis for Fortrea Holdings. That backdrop helps explain why, despite a sharp 1 month share price return of about 26 percent and a 90 day share price gain above 20 percent off the lows, Fortrea’s year to date share price return remains...
  Dec 3, 2025 - $FTRE
• Does Fortrea’s (FTRE) Debt Buyback Mark a Shift in Its Post-Divestiture Financial Strategy?
  Fortrea Holdings recently completed a debt tender offer to repurchase US$75.74 million of its 7.500% Senior Secured Notes due 2030, reducing the outstanding principal in connection with earlier business divestitures finalized in June 2024. This action fulfills debt reduction commitments linked to its past divestitures and may enhance Fortrea’s financial flexibility for future operations. We’ll explore how Fortrea’s substantial reduction in outstanding debt influences the company's investment...
  Nov 26, 2025 - $FTRE